HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study.

Abstract
To investigate to which extent lamotrigine (LTG) may be effective and tolerated as a monotherapy for the treatment of newly diagnosed childhood absence seizures and, secondly, to evaluate the efficacy of this drug on the circadian interictal generalized epileptiform discharges, 20 consecutive newly diagnosed patients (five males, 15 females), aged 3-10 years (mean 6.9 years), affected by childhood absence epilepsy, were administered LTG as first-line drug at the initial dose of 0.5 mg/kg/day for 2 weeks, followed by 1.0 mg/kg/day for an additional 2 weeks. Thereafter, doses have been increased in 1-mg/kg/day increments up to 9-12 mg/kg/day in accordance with the clinical response. Each patient underwent an ambulatory (24 h) EEG monitoring before starting LTG therapy (time 0) and during the maintenance period at the end of LTG titration (time 1). After a mean follow-up period of 10.8 months (range 3-28 months), a 100% seizure control was obtained in 11 children (55.5%), a more than 75% seizure decrease was present in four (20%), and a >50% seizure decrease in five (25%), with a mean LTG dose of 6.2 mg/kg/day (range 1.2-11) in the controlled group. Adverse events were present in three patients (15%); they were generally mild and transient. Our series confirms that LTG monotherapy may control typical childhood absence seizures in about half the children as well as it may decrease interictal generalized spike and wave discharges both in seizure-free and uncontrolled patients. The slow titration phase of the drug due to the risk of the skin rash may eventually reduce compliance.
AuthorsGiangennaro Coppola, Felicia Licciardi, Nicola Sciscio, Francesco Russo, Marco Carotenuto, Antonio Pascotto
JournalBrain & development (Brain Dev) Vol. 26 Issue 1 Pg. 26-9 (Jan 2004) ISSN: 0387-7604 [Print] Netherlands
PMID14729411 (Publication Type: Journal Article)
Chemical References
  • Anticonvulsants
  • Triazines
  • Lamotrigine
Topics
  • Anticonvulsants (administration & dosage, adverse effects)
  • Child
  • Child, Preschool
  • Drug Administration Schedule
  • Electroencephalography
  • Epilepsy, Absence (drug therapy)
  • Female
  • Humans
  • Lamotrigine
  • Male
  • Triazines (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: